Profound Medical Corp.
Profound Medical Corp. (PROF) Stock Overview
Explore Profound Medical Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
166.7M
P/E Ratio
4.02
EPS (TTM)
$-1.36
ROE
0.79%
PROF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Profound Medical Corp. (PROF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.02 and a market capitalization of 166.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.